Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  21 results for ""BNT162 Vaccine""

Your Filters

Publication : emerging microbes infections
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Waning effectiveness against COVID-19-related hospitalization, severe complications, and mortality with two to three doses of CoronaVac and BNT162b2: a case-control study.

  • Authors : Yan VKC; Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, Centre for Safe Medication Practice and Research, The University of Hong Kong, Hong Kong, People's Republic of China.; Wan EYF

Subjects: BNT162 Vaccine* ; COVID-19*/COVID-19*/COVID-19*/therapy; Humans

  • Source: Emerging microbes & infections [Emerg Microbes Infect] 2023 Dec; Vol. 12 (1), pp. 2209201.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101594885 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Editorial & Opinion

Increase over time of antibody levels 3 months after a booster dose as an indication of better protection against Omicron infection.

  • Authors : Bingula R; UMR UNH, ECREIN, Immunology Laboratory, Faculty of Medicine, Clermont Auvergne University, Clermont-Ferrand, France.; Chabrolles H

Subjects: BNT162 Vaccine* ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Humans SARS-CoV-2 variants

  • Source: Emerging microbes & infections [Emerg Microbes Infect] 2023 Dec; Vol. 12 (1), pp. 2184176.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101594885 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Medium-term outcomes of myocarditis and pericarditis following BNT162b2 vaccination among adolescents in Hong Kong.

  • Authors : Chua GT; Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, People's Republic of China.; Department of Paediatrics and Adolescent Medicine, The Hong Kong Children's Hospital, Hong Kong SAR, People's Republic of China.

Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/adverse effects ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Myocarditis*/Myocarditis*/Myocarditis*/diagnosis

  • Source: Emerging microbes & infections [Emerg Microbes Infect] 2022 Dec; Vol. 11 (1), pp. 2466-2473.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101594885 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Adverse events of special interest following the use of BNT162b2 in adolescents: a population-based retrospective cohort study.

  • Authors : Lai FTT; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China.; Laboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Hong Kong Science and Technology Park, Hong Kong Special Administrative Region, People's Republic of China.

Subjects: BNT162 Vaccine* ; COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: Emerging microbes & infections [Emerg Microbes Infect] 2022 Dec; Vol. 11 (1), pp. 885-893.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101594885 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Effectiveness of BNT162b2 and CoronaVac vaccinations against mortality and severe complications after SARS-CoV-2 Omicron BA.2 infection: a case-control study.

  • Authors : Yan VKC; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, People's Republic of China.; Wan EYF

Subjects: BNT162 Vaccine* ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Adult

  • Source: Emerging microbes & infections [Emerg Microbes Infect] 2022 Dec; Vol. 11 (1), pp. 2304-2314.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101594885 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

SARS-CoV-2 mRNA vaccine BNT162b2 triggers a consistent cross-variant humoral and cellular response.

  • Authors : Mileto D; Laboratory of Clinical Microbiology, Virology and Bioemergencies, ASST Fatebenefratelli Sacco, L. Sacco University Hospital, Milan, Italy.; Fenizia C

Subjects: BNT162 Vaccine/BNT162 Vaccine/BNT162 Vaccine/*immunology ; COVID-19/COVID-19/COVID-19/*immunology ; COVID-19/COVID-19/COVID-19/*prevention & control SARS-CoV-2 variants

  • Source: Emerging microbes & infections [Emerg Microbes Infect] 2021 Dec; Vol. 10 (1), pp. 2235-2243.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101594885 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Editorial & Opinion

Ad26.COV2.S boosts antibody and T-cell responses following BNT162b2 vaccination.

  • Authors : Iketani S; Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.; Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA.

Subjects: Ad26COVS1/Ad26COVS1/Ad26COVS1/*administration & dosage ; BNT162 Vaccine/BNT162 Vaccine/BNT162 Vaccine/*administration & dosage ; COVID-19/COVID-19/COVID-19/*prevention & control

  • Source: Emerging microbes & infections [Emerg Microbes Infect] 2021 Dec; Vol. 10 (1), pp. 2220-2222.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101594885 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Real-life effectiveness of COVID-19 vaccine during the Omicron variant-dominant pandemic: how many booster doses do we need?

  • Authors : Sritipsukho P; Center of Excellence in Applied Epidemiology, Thammasat University, Pathumthani, Thailand.; Department of Pediatrics, Faculty of Medicine, Thammasat University, Pathumthani, Thailand.

Subjects: COVID-19 Vaccines* ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Adult SARS-CoV-2 variants

  • Source: Emerging microbes & infections [Emerg Microbes Infect] 2023 Dec; Vol. 12 (1), pp. 2174779.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101594885 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Effectiveness of BNT162b2 and CoronaVac vaccines in preventing SARS-CoV-2 Omicron infections, hospitalizations, and severe complications in the pediatric population in Hong Kong: a case-control study.

  • Authors : Yan VKC; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, People's Republic of China.; Cheng FWT

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*

  • Source: Emerging microbes & infections [Emerg Microbes Infect] 2023 Dec; Vol. 12 (1), pp. 2185455.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101594885 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Structural insights into broadly neutralizing antibodies elicited by hybrid immunity against SARS-CoV-2.

  • Authors : Luo M; AIDS Institute, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People's Republic of China.; Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People's Republic of China.

Subjects: SARS-CoV-2* ; COVID-19*; Humans SARS-CoV-2 variants

  • Source: Emerging microbes & infections [Emerg Microbes Infect] 2023 Dec; Vol. 12 (1), pp. 2146538.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101594885 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  21 results for ""BNT162 Vaccine""